Open access · CC-BY
via OpenAlex
Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer
Dan Feng, Jian Zhang, Huanmin Niu, Xiaoxue Zheng, Mengqi Jia, Qiqi Lu, Jinglong Wang, Wen-xue Guo, Qi Sun, Huiqing Yuan, Hong‐Xiang Lou
Acta Pharmaceutica Sinica B · 2025 · ▲ 11 citations
Abstract
The elevated polyamines, amine-rich molecules with diverse functions in pathophysiology processes, are implicated in contributing to tumorigenesis and progression. Whether and how they affect the efficacy of chemotherapy is incompletely understood. Our screening assays reveal that the supplement with a low dose of spermidine (Spd), one of the polyamines, enhances ferroptosis in prostate cancer cells as evidenced by increased lipid peroxidation and intracellular Fe 2+ levels in vitro . Combination treatment with Spd and a low dose of ferroptosis inducer erastin synergistically augments anti-tumor efficacy with undetectable toxicity in mice. Analysis of RNA-seq data indicates that heme oxygenase 1 (HMOX1), an enzyme that catalyzes the cleavage of heme to release Fe 2+ , is significantly upregulated in response to Spd and erastin cotreatment. Spd mediated the hypusine modification of the eukaryotic initiation factor 5A (EIF5A) promotes the translation of the nuclear factor erythroid 2-related factor 2 (NRF2), subsequently leading to elevation of HMOX1. Moreover, Spd and erastin significantly inhibit proteasome activity which results in a decrease in proteasomal degradation of NRF2, although many proteasome-related genes are induced either by Spd or Spd plus erastin. Thus, in addition to its pro-oncogenic activity, the supplement of Spd improves antitumor activity in combination with ferroptosis inducers and offers an optional approach to cancer treatment. Spermidine-mediated hypusine modification of EIF5A and proteasome inhibition led to the accumulation of NRF2 protein, resulting in the overactivation of HMOX1 to release Fe 2+ to promote erastin-induced ferroptosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.apsb.2025.02.023
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Feng, D., Zhang, J., Niu, H., Zheng, X., Jia, M., Lu, Q., Wang, J., Guo, W., Sun, Q., Yuan, H., & Lou, H. (2025). Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer. <em>Acta Pharmaceutica Sinica B</em>. https://doi.org/10.1016/j.apsb.2025.02.023
Vancouver
Feng D, Zhang J, Niu H, Zheng X, Jia M, Lu Q, et al. Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer. Acta Pharmaceutica Sinica B. 2025. doi:10.1016/j.apsb.2025.02.023.
BibTeX
@article{dan2025Spermi,
title = {Spermidine inactivates proteasome activity and enhances ferroptosis in prostate cancer},
author = {Dan Feng and Jian Zhang and Huanmin Niu and Xiaoxue Zheng and Mengqi Jia and Qiqi Lu and Jinglong Wang and Wen-xue Guo and Qi Sun and Huiqing Yuan and Hong‐Xiang Lou},
journal = {Acta Pharmaceutica Sinica B},
year = {2025},
doi = {10.1016/j.apsb.2025.02.023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Neuroscience 2004
Open access · CC-BY
Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation
Biochemical Journal 2025
Open access · CC-BY
Opposite effects of spermidine and GC7 in cell culture are dictated by distinct molecular targets
eScholarship (California Digital Library) 2009
Preprint · OA
Extension of the Lifespan of Caenorhabditis elegans by the Somatic Reproductive Tissues
biorxiv 2025
Preprint · CC-BY
A novel vimentin variant from tumor-associated macrophages directs cancer metastasis by engaging IGF-1R
Journal of Biological Chemistry 2011
Open access · CC-BY
Tumor Suppressor and Aging Biomarker p16INK4a Induces Cellular Senescence without the Associated Inflammatory Secretory Phenotype
Journal of Cell Science 2004
Open access · OA